A Catenary Model to Study Transport and Conjugation of Baicalein, a Bioactive Flavonoid, in the Caco-2 Cell Monolayer: Demonstration of Substrate Inhibition
Authors:
- Li ZhangLZLi Zhang
- Edwin Chiu Yuen ChowECEdwin Chiu Yuen Chow
- Ge LinGLGe Lin
- Zhong ZuoZZZhong Zuo
- K. Sandy PangKPK. Sandy Pang
- 1 July 2008
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 326 (1) , 117-126
Abstract
The transport and metabolism of baicalein (Ba) was studied in vitro and in Caco-2 cells. Protein binding of Ba with Caco-2 lysate showed that Ba was bound to two classes of sites: a higher affinity, lower capacity site (KA1 = 27.6 ± 4.7 μM–1, n1 = 10.6 ± 0.6 nmol/mg) and lower affinity, higher capacity site (KA2 = 0.015 ± 0.0013 μM–1, n2 = 413 ± 21 nmol/mg). Incubation studies of Ba with Caco-2 lysate showed substrate inhibition of both glucuronidation and sulfation, with Km values of 0.14 ± 0.034 and 0.015 ± 0.0053 μM, and KI values of 6.75 ± 1.70 and 0.37 ± 0.16 μM, respectively. In the Caco-2 monolayer, Ba (8–47 μM) displayed good apparent permeabilities (Papp) across the membrane; Papp was found to be increased with elevated loading concentration in both the absorptive and secretory directions. However, the efflux ratio was less than unity, negating the involvement of apical efflux transporters. The concentration ratios of Ba sulfate (BS) and glucuronide (BG) decreased with increased loading Ba concentration, suggesting that BS and BG are apically excreted via transporters, likely breast cancer resistance protein and multidrug resistance-associated protein 2, respectively. Data fit to the catenary model, composed of basolateral, cellular, and apical compartments, showed a low cellular unbound fraction (0.0019 ± 0.00018), a high passive diffusion clearance (0.012 ± 0.00029 ml/min/mg), and substrate inhibition, with sulfation being more readily saturated and inhibited than glucuronidation, as evidenced by smaller Km value (0.35 ± 0.078 versus 1.95 ± 0.57 μM) and KI value (0.58 ± 0.20 versus 7.90 ± 1.10 μM); these patterns paralleled those observed in the lysate incubation studies. The results showed that the catenary model aptly predicts substrate inhibition kinetics and offers significant and mechanistic insight into the transport and atypical metabolism of drugs in the Caco-2 monolayer.Keywords
This publication has 40 references indexed in Scilit:
- Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein DegradationMolecular Pharmacology, 2006
- Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetinJournal of Pharmacy and Pharmacology, 2005
- Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer modelInternational Journal of Pharmaceutics, 2004
- HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECIDDrug Metabolism and Disposition, 2004
- Modeling Kinetic Data from In Vitro Drug Metabolism Enzyme ExperimentsDrug Metabolism Reviews, 2004
- Quantitative Approaches to Delineate Passive Transport Mechanisms in Cell Culture Monolayers1999
- Selective separation of flavonoids with a polyvinyl alcohol membraneJournal of Membrane Science, 1996
- Passive Diffusion of Weak Organic Electrolytes across Caco‐2 Cell Monolayers: Uncoupling the Contributions of Hydrodynamic, Transcellular, and Paracellular BarriersJournal of Pharmaceutical Sciences, 1995
- Use of a Biophysical-Kinetic Model to Understand the Roles of Protein Binding and Membrane Partitioning on Passive Diffusion of Highly Lipophilic Molecules Across Cellular BarriersJournal of Drug Targeting, 1993
- Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colonThe Journal of Membrane Biology, 1987